Adenosine deaminase (ADA) activity and free interleukin (IL)-2 receptor levels were assayed in serum samples from patients with mycoplasmaand bacterial pneumoniato evaluate the usefulness of these parameters in distinguishing between these diseases at an early stage. Serum ADAand free IL-2 receptor levels in patients with mycoplasma pneumonia (32.4 ± 9.2 U/l, 960 ± 204 U/ml) were significantly higher than those in patients with bacterial pneumonia (12.5± 3.3 U/l, 425± 86 U/ml) and in healthy controls (14.0±3.4 U/l, 286± 49 U/ml) (p <0.001). Of the 20 mycoplasma pneumonia cases, 19 showed increased levels of ADAover 20.8 U/l; in 17 of the 19, the increase of ADAwas seen before the elevation of the specific antibody to Mycoplasma pneumoniae. In contrast, serum ADAlevels in all 20 cases of bacterial pneumonia were lower than 20.8 U/l. These results indicate that assays for serum ADAand free IL-2 receptor levels are useful in distinguishing between bacterial and mycoplasmapneumonia at an early stage.
Unlike bacterial pneumonia, the pathogenesis of mycoplasma pneumonia is thought to involve immune mechanisms, particularly T cells (1) (2) (3) (4) . Adenosine deaminase (ADA) activity is high in lymphoid tissue, particularly precursor T lymphocytes (5) , and higher in peripheral T cells than in B cells (6) . ADAis thought to be required for induction of T cell (7) and monocyte (8) 
Clinically, an elevation of ADAactivity in serum and thoracic fluid has been found in diseases involving cell-mediated immunity (9-12). The expression of the interleukin (IL)-2 receptor occurs when T cells are activated by stimulants such as mitogen or antigen (13). Free IL-2 receptor in the serum is a sensitive index of the IL-2 receptor status (14-16) and its elevation in adult T cell leukemia reflects increased levels of activated, proliferating T cells (17) . In cases of acute pneumonia, determination of the pathogen directly affects the therapeutic regimen.
During the early stages, the pathogen for acute pneumonia is speculated from symptoms, leukocyte count, and chest X-ray findings. Mycoplasma pneumonia is characterized by an intense, dry cough present from the onset, interstitial shadow on chest X-ray films, and the absence of leukocytosis. It is frequently treated with tetracycline or macrolide antibiotics. In some cases, however, beta-lactam antibiotics, ineffective in this type of pneumonia, are used at the early stage based on a suspicion of bacterial pneumonia. In addition, there are cases where a diagnosis of mycoplasmapneumoniais made based on the finding of an elevated specific antibody to Mycoplasma pneumoniae during patient follow-up. The distinction between mycoplasma and bacterial pneumonia has been frequently difficult at ADA,Free IL-2R in Mycoplasma Pneumonia to M. pneumoniae, and no effective auxiliary diagnostic tool has been available. If a distinction between mycoplasma and bacterial pneumonia is possible at an early stage, moreappropriate treatment can be applied. Therefore, serum ADAactivity and free IL-2 receptor levels were assayed in pneumonia patients to elucidate the differences in immunological responses between mycoplasma and bacterial pneumonia and to assess the usefulness of these parameters for early diagnosis.
SUBJECTS AND METHODS

Su bjects
Included were 40 cases of pneumonia, without underlying diseases, who visited our department or related institutions within 10 days after onset and whowere subsequently treated as inpatients from July 1984 to January 1989. There were 20 cases of mycoplasma pneumonia (15 males and 5 females), with ages ranging from 20 to 43 yr (mean: 33.4 yr), and 20 cases of bacterial pneumonia (16 males and 4 females), with ages ranging from 18 to 48 yr (mean: 33.9 yr). Thirty healthy volunteers (15 males and 15 females), with ages ranging from 22 to 53 yr (mean: 38.6 yr), served as controls, Onset and diagnosis of pneumonia The day when symptoms of respiratory infection, such as fever and cough, appeared was regarded as the day of disease onset.
A diagnosis of mycoplasma pneumonia was made when the antibody titer to Mycoplasma pneumoniaein a single serum sample was elevated to 64-fold or more by the complement fixation test or to 320-fold or more by the indirect hemagglutination test, or whenthe titer in paired serum samples showed a 4-fold or more increase. In 20 cases diagnosed as having bacterial pneumonia, antibody titer to M. pneumoniae and cold agglutination showed no elevation, leukocytosis was present, and a significant pathogen was found in the sputum. All cases of bacterial pneumonia responded to therapy with beta-lactam antibiotics.
Cases of atypical pneumonia, which showed a clinical course similar to mycoplasmapneumonia but also showed an elevated cold agglutination and no elevation of antibody to M. pneumoniae, were excluded from this study.
Extent of infiltrates on chest X-ray films
The extent of infiltrates on chest X-ray films, which were taken at the first measurement of ADA, were classified on a four-grade scale: score 0, no shadow; score 1, a focal shadow not exceeding one intercostal space; score 3, a shadow covering one lobe or more; score 2, a shadowarea betweenscores 1 and3.
Assay for ADA ADAwas determined according to the method of Guisti (18). Serum (0.05 ml) was incubated for 60 min at 37°C in 1.0 ml of buffered adenosine solution (21 mMadenosine and 50 mMphosphate). Then 3.0 ml of phenol-nitroprussid solution (106 mMphenol and 0. 17 mMsodium nitroprussid) and 3.0 ml of alkaline hypochlorite solution (1 1 mM NaOCland 125 mMNaOH)were added. The solution was incubated for 30 min at 37°C, and then was measuredwith a spectrometer at 626 nm.
standard-reagent blank y v } Assay for free IL-2 receptor
Free IL-2 receptor was determined by ELISA using a cell free IL-2 receptor kit (T-cell Sciences, MA).
Statistical analysis
Values were expressed as mean ± SD. Statistical significance of differences was tested by the Student's t-test with p <0.05 regarded as significant.
RESULTS
The interval from disease onset to the first examination of serum ADAwas within 10 days in all cases and did not significantly differ between mycoplasma pneumonia (6 ± 2.5 days) and bacterial pneumonia and healthy controls (p <0.001, Fig. 1 ).
In 19 of the 20 cases of mycoplasma pneumonia, serum ADAexceeded 20.8 U/l, which was the mean activity of the healthy controls + 2SD. On the other hand, none of the 20 cases of bacterial pneumonia exceeded 20.8 U/l. In the relationship between ADAactivity and the extent of infiltrates on chest X-ray films in patients with mycoplasma pneumonia, the cases with a score of 3 tended to show a higher ADA activity (42.8±15.5 U/l; n=3) than the score 2 cases (30.6±6.9 U/l; n=12) or score 1 (30.9±6.0 U/l; n = 5), though there was no correlation between the ADAactivity and the extent of infiltrates (Fig. 2 ). In patients with mycoplasma pneumonia, ADA activity did not correlate with the interval from disease onset to the first ADAexamination (3-10 days), with the antibody titer to M. pneumoniae, leukocyte count, peripheral lymphocyte count, C-reactive protein, or cold agglutination (data not shown). In 17 of 20 cases of mycoplasma pneumonia, antibody to M. pneumoniae was negative in the early stage between 3 and 10 days after disease onset, while serum ADAwas elevated.
In five healthy controls in which the free IL-2 ADA, Free IL-2R in Mycoplasma Pneumonia receptor level in the serum was determined, the mean was 286±49 U/ml. For ten cases of bacterial pneumonia, the meanfree IL-2 receptor level was somewhat higher (425 ± 86 U/ml; 325-644 U/ml), although the difference was not statistically significant. The free IL-2 receptor values for six cases of mycoplasma pneumonia (960±250 U/ml; 637-1 ,240 U/ml) were significantly higher than in healthy controls and cases of bacterial pneumonia (p<0.001, Fig. 3 ).
DISCUSSION
The present study showed that the level of serum ADA and free IL-2 receptor in patients with mycoplasmapneumonia was significantly higher than in patients with bacterial pneumonia and in healthy controls, and that the elevation of ADAin mycoplasma pneumonia occurs in the early stage before the elevation of the specific antibody to M pneumoniae. These results indicate that the immunological responses to mycoplasma and bacterial pneumonia differ, and that the assay of ADAand free IL-2 receptor in the serum is useful for early diagnosis of mycoplasmapneumonia.
It has been demonstrated both experimentally and clinically that humoral immunity and cellmediated immunity are established following mycoplasma infection (1) (2) (3) (4) . Mycoplasma-related factors known to induce pneumonia include toxin of mycoplasma, tissue injury due to nonspecific inflammatory reaction, and lung injury due to an immune mechanism mediated by T cells.
Lymphocyteinfiltration and activation, particularly of T cells, has been found in inflamed regions of the lung (19). Severe mycoplasma pneumonia has been attributed to temporary regional immunological hypersensitivity of the lungs (20). The present study with ADAand free IL-2 receptors, which are indicators of T cell activation, also supports the concept that T cell activation occurs in patients with mycoplasma pneumonia. Perhaps the most interesting finding was that serum ADA in patients with mycoplasma pneumoniawas increased at the early stage between the 3rd and 10th day after disease onset, i.e., before elevation of specific antibody to M. pneumoniae. of mycoplasma pneumonia, ADAactivity did not exceed the mean ± 2SD of healthy controls. In this case, ADAon the fifth day after onset was 18.7 U/l, chest X-ray shadow was rated as score 2, leukocytosis was absent, and treatment with beta-lactam was ineffective, but treatment with clindermycin and erythromycin was effective. Antibodies to M. pneumoniae showed a 4-fold increase in paired serum samples, but cold agglutination was low. Clinically, this case did not differ from the other cases of mycoplasmapneumoniaexcept that the ADAactivity on the fifth day after onset and cold agglutination were low. The reason for the low ADA activity in this case was not determined. From the third to tenth day after disease onset, no correlation was found between the interval from onset to the first ADAassay and the ADAactivity. Serum ADAis known to rise following hepatic impairment (21). However,when liver function was examined in 12 of 20 patients with mycoplasma pneumonia, no abnormality indicative of hepatic impairment was found. Changes in ADAactivity throughout the course of mycoplasmapneumoniaand after its cure need further investigation.
In patients with mycoplasmapneumonia, ADA Jpn J Med Vol 30, No 2 (March, April 1991) Ill activity did not consistently correlate with the extent of infiltrates on chest X-ray, although ADAactivity tended to be high in cases showing a shadow exceeding one lobe. Even though the number of cases examined was too small to allow for sufficient statistical analysis, it seems unlikely, judging from the leukocyte count and sputum culture, that secondary bacterial infection (sometimes seen during mycoplasma pneumonia) affected chest X-ray findings. If ADAcorrelates with T cell activation, the above-mentioned chest X-ray findings may be explained by the fact that regional immuneresponses are not always reflected in peripheral blood, that there is a time lag between the peak of immunological response and the peak of chest X-ray shadow, or that factors other than immunological mechanisms may be involved in the regional inflammatory reaction. In the present study, the reason remains obscure.
